Potently bioactive agents of the specialized proresolving mediator class include:
* DHA-derived resolvins (Rvs) of the D series: RvD1, RvD2, RvD3, RvD4, RvD5, RvD6, AT-RvD1, AT-RvD2, AT-RvD3, AT-RvD4, AT-RvD5, and AT-RvD6.
* n-3 DPA-derived resolvins of the D series (RvD1, RvD2, and RvD5) and the T series (RvT1, RvT2, RvT3, and RvT4).
* DHA-derived neuroprotectins, also termed protectins: PD1, PDX, 17-epi-PD1, and 10-epi-PD1.
* n-3 DPA derived protectins: PD1 and PD2. 
* DHA-derived maresins: MaR1, MaR2, 7-epi-Mar1, Mar-L1, and Mar-L2.
* n-3 DPA-derived maresins: Mar1, Mar2, and Mar3.
These DHA metabolites possess anti-inflammation and tissue-protection activities in animal models of inflammatory diseases; they are proposed to inhibit innate immune responses and thereby to protect from and to resolve a wide range of inflammatory responses in animals and humans. These metabolites are also proposed to contribute to the anti-inflammatory and other beneficial effects of dietary omega-3 fatty acids by being metabolized to them.